Biomet CEO: Medtech helps curb healthcare costs | MassDevice.com On Call (MassDevice)
Biomet CEO Jeffrey Binder defends medical devices against reports that paint technology as a significant contributor to the ever-rising cost of U.S. healthcare
Recent data exposures from the Centers for Medicare & Medicaid have raised eyebrows about the cost of U.S. healthcare and variability among care providers, but Biomet CEO Jeffrey Binder insists that medical devices are not to blame.
In a new editorial written for Philly.com, Binder defended the industry and its role in the ever-rising cost of U.S. ...
